CN113774038B - Isatis tinctoria caffeic acid-O-methyltransferase protein, encoding gene and application thereof - Google Patents
Isatis tinctoria caffeic acid-O-methyltransferase protein, encoding gene and application thereof Download PDFInfo
- Publication number
- CN113774038B CN113774038B CN202111031460.7A CN202111031460A CN113774038B CN 113774038 B CN113774038 B CN 113774038B CN 202111031460 A CN202111031460 A CN 202111031460A CN 113774038 B CN113774038 B CN 113774038B
- Authority
- CN
- China
- Prior art keywords
- leu
- lys
- gly
- val
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to the field of bioengineering and medicine, and discloses a woad caffeic acid-O-methyltransferase COMT protein and a coding gene thereof, wherein the woad caffeic acid-O-methyltransferase can catalyze methylation reaction of caffeic acid and derivatives, in particular to methylation of phenolic hydroxyl groups. Therefore, the invention can improve the biosynthesis efficiency of the antiviral active ingredient larceny in the woad by a genetic engineering technology, can be applied to ferulic acid, sinapic acid, rhamnoxin, isorhamnetin and chrysoeriol, provides conditions for the mass production of the active ingredients of the traditional Chinese medicinal materials, and has wide application prospect and market value.
Description
Technical Field
The invention relates to the field of bioengineering and medicine, and in particular discloses woad caffeic acid-O-methyltransferase COMT protein, and a coding gene and application thereof.
Background
Isatis tinctoria (Isatis indigotica fort.) is a plant of Isatis genus of Brassicaceae, and has effects of clearing away heat and toxic materials, cooling blood, removing speckle, relieving sore throat, and relieving pain. The isatis root and the dyers woad leaf are clinically used for influenza, epidemic encephalitis B, epidemic parotitis, acute and chronic hepatitis, herpes zoster, osteomyelitis and other diseases.
The radix isatidis has wide pharmacological actions including resisting pathogenic microorganism, resisting bacteria, resisting virus, resisting endotoxin, resisting inflammation, etc. The subject group obtains tetraploid woad fine strain with high yield, high resistance and high antiviral activity through polyploid breeding in the early stage. Chemical composition researches show that lignans components represented by larch extract are important substance basis for the isatis tinctoria to exert antiviral effect.
The biosynthetic pathway of lignans in plants has been initially ascertained, starting from the deamination of phenylalanine to cinnamic acid via the phenylalanine pathway, by a series of hydroxylations, methylation and reduction reactions, in which the lignan monomer coniferyl alcohol is first produced, which in turn produces larch-leaf pinoresinol by polymerization and reduction. It can be seen that coniferyl alcohol is an important precursor compound for the formation of larceny, and its synthesis requires the involvement of a variety of enzymes, such as Phenylalanine Ammonia Lyase (PAL), cinnamic acid-4-hydroxylase (C4H), coumaric acid-3-hydroxylase (C3H), 4-coumaroyl-coa ligase (4 CL), caffeoyl-coa oxymethyl transferase (CCoAOMT), cinnamyl Alcohol Dehydrogenase (CAD), caffeic acid-O-methyltransferase (COMT), and the like. Wherein, caffeic acid-O-methyltransferase (COMT) can catalyze caffeic acid O-methyltransgerase to directly generate coniferyl alcohol, which is an important precursor for biosynthesis of antiviral active ingredient larch resin in Isatis tinctoria. Therefore, caffeic acid-O-methyltransferase is one of key enzymes for biosynthesis of lignans, mainly takes adenosylmethionine (SAM) as methyl donor, can catalyze methylation of various substrates, and belongs to the field of non-Mg requirement 2+ The COMT protein has an average relative molecular mass of about 40kDa and is mainly localized in the cytoskeleton and cytoplasm.
The invention aims to obtain COMT genes and expressed proteins from Isatis tinctoria, and provides conditions for improving lignanoid active substances in Isatis tinctoria by genetic engineering technology.
Disclosure of Invention
The invention aims to provide woad caffeic acid-O-methyltransferase protein and a coding gene thereof.
The invention also provides application of the protein and the gene.
The technical scheme of the invention is as follows:
isatis tinctoria caffeic acid-O-methyltransferase, the amino acid sequence of which contains any one of the sequences of SEQ ID No. 1-4. Preferably, the amino acid sequence is any one of SEQ ID No. 1-4.
Specifically, isatis tinctoria caffeic acid-O-methyltransferase IiCOMT1, the amino acid sequence of which contains the sequence of SEQ ID No.1; preferably, the amino acid sequence of the polypeptide is shown as SEQ ID No.1;
isatis tinctoria caffeic acid-O-methyltransferase IiCOMT2, the amino acid sequence of which contains SEQ ID 2 sequence; preferably, the amino acid sequence is shown as SEQ ID No.2;
isatis tinctoria caffeic acid-O-methyltransferase IiCOMT3, the amino acid sequence of which contains SEQ ID No.3 sequence; preferably, the amino acid sequence is shown as SEQ ID No.3;
isatis tinctoria caffeic acid-O-methyltransferase IiCOMT4, the amino acid sequence of which contains SEQ ID No.4 sequence; preferably, the amino acid sequence is shown as SEQ ID No.4.
Isatis tinctoria caffeic acid-O-methyltransferase genes encoding the above-mentioned Isatis tinctoria caffeic acid-O-methyltransferase.
Preferably, said Isatis tinctoria caffeic acid-O-methyltransferase gene encodes any one of the above-mentioned SEQ ID No.1-4 sequences. Further, the nucleotide sequence thereof contains any one of SEQ ID No.5-8 sequences. Preferably, the nucleotide sequence is any one of SEQ ID No. 5-8.
Specifically, the Isatis tinctoria caffeic acid-O-methyltransferase gene encodes the protein of SEQ ID No.1 described above. Further, the nucleotide sequence thereof contains the sequence of SEQ ID No. 5; more preferably, the nucleotide sequence is shown as SEQ ID No.5.
The Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT2 gene, which encodes the protein of SEQ ID No.2 as described above. Further, the nucleotide sequence thereof contains the sequence of SEQ ID No. 6; more preferably, the nucleotide sequence is shown as SEQ ID No.6.
The Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT3 gene, which encodes the protein of SEQ ID No.3 as described above. Further, the nucleotide sequence thereof contains the sequence of SEQ ID No. 7; more preferably, the nucleotide sequence is shown as SEQ ID No.7.
The Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT4 gene, encodes the protein of SEQ ID No.4 as described above. Further, the nucleotide sequence thereof contains the sequence of SEQ ID No. 8; more preferably, the nucleotide sequence is shown as SEQ ID No.8.
A recombinant vector comprising a gene encoding any one of the above-mentioned woad caffeic acid-O-methyltransferase; preferably, the Isatis tinctoria caffeic acid-O-methyltransferase gene is contained. More preferably, it contains any one of the nucleotide sequences of SEQ ID No. 5-8.
A host cell containing a woad caffeic acid-O-methyltransferase gene, or a host cell containing the above recombinant vector.
Preferably, the host cell is E.coli.
The above-mentioned woad caffeic acid-O-methyltransferase, woad caffeic acid-O-methyltransferase gene, transformation vector or host cell can be used for catalyzing methylation reaction of caffeic acid and derivatives, especially methylation of phenolic hydroxyl groups.
The methylation reaction comprises the following reactions: catalyzing the methylation of caffeol to coniferyl alcohol, 5-hydroxyferulic acid (5-hydroxyferulic acid) to sinapic acid, quercetin to isomouse Li Suyi, and luteolin to chrysoeriol.
Thus, woad caffeic acid-O-methyltransferase genes, transformation vectors or host cells may be used to prepare catalysts for catalyzing the methylation of caffeic acid and derivatives.
The invention also discloses a method for methylation of caffeic acid and derivatives, which takes caffeic acid and derivatives as raw materials, and woad caffeic acid-O-methyltransferase, a recombinant vector or host cell capable of expressing woad caffeic acid-O-methyltransferase as a catalyst. Specifically, the following methylation reactions are included: the methylation of caffeol to coniferyl alcohol, 5-hydroxyferulic acid (5-hydroxyferulic acid) to sinapic acid, the methylation of quercetin to isorhamnetin, and the methylation of luteolin to chrysoeriol.
The invention obtains 4 woad caffeic acid-O-methyltransferase genes from woad and uses the genes for expressing proteins to obtain the encoded proteins. The obtained protease has good catalytic activity, can catalyze the methylation reaction of caffeic acid and derivatives, for example, can catalyze the methylation of caffeol to generate coniferyl alcohol, and is one of important key enzymes for the biosynthesis of lignans.
Therefore, the invention can improve the biosynthesis efficiency of the antiviral active ingredient larceny in the woad by a genetic engineering technology, can be applied to ferulic acid, sinapic acid, rhamnoxin, isorhamnetin and chrysoeriol, provides conditions for the mass production of the active ingredients of the traditional Chinese medicinal materials, and has wide application prospect and market value.
Drawings
FIG. 1 is a diagram showing 0.8% agarose gel electrophoresis of PCR products of Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT1-4 gene amplified from a Isatis tinctoria leaf cDNA library in example 1.
FIG. 2 is a diagram showing 0.8% agarose gel electrophoresis of a PCR product of a monoclonal positive bacterial Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT1-4 gene in example 1.
FIG. 3 is a diagram showing the electrophoresis of PCR products of the Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT1-4 gene as a prokaryotic expression vector in example 2 using 0.8% agarose gel.
FIG. 4 is a diagram showing crude protein electrophoresis of Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT1-4 after protein induction in example 3.
FIG. 5 is a protein electrophoresis pattern of Isatis tinctoria caffeic acid-O-methyltransferase IiCOMT1-4 after protein-induced expression and concentration purification in example 3.
FIG. 6 is a linear regression equation for concentration and absorbance of the standard protein solution in example 3.
FIG. 7 is an HPLC chromatogram of the reaction solution of IiCOMTs catalyzed caffeic acid to ferulic acid in example 4.
FIG. 8 is a HPLC chromatogram of example 4 in which IiCOMTs catalyze the formation of coniferyl alcohol from caffeol.
FIG. 9 is a HPLC chromatogram of example 4 in which IiCOMTs catalyze 5-hydroxyferulic acid to give sinapic acid reaction.
FIG. 10 is a HPLC chromatogram of an IiCOMTs catalyzed quercetin to isorhamnetin reaction solution in example 4.
FIG. 11 is a HPLC chromatogram of the reaction solution of luteolin to chrysoeriol catalyzed by IiCOMTs in example 4.
Detailed Description
Example 1
1. Isatis tinctoria leaf RNA extraction
a. Sample collection: taking fresh Isatis tinctoria leaves, wrapping the fresh Isatis tinctoria leaves with aluminum foil, and then placing the wrapped Isatis tinctoria leaves into liquid nitrogen; quick-freezing with liquid nitrogen, taking out, knocking, transferring the sample into a 1.5ml RNase-free centrifuge tube containing two steel balls, and grinding with a ball mill.
b. Extracting RNA: sample lysis, extraction and delamination, column recovery, washing and centrifugation, and RNA elution (experimental procedure reference kit TransZol Up Plus RNA Kit full gold ER 501).
c. The concentration and purity of the obtained RNA were measured, and the results are shown in Table 1.
TABLE 1
Sample of | C(ng/mL) | A260/A280 | A260/A230 |
Isatis tinctoria tender leaf | 848.2 | 2.12 | 2.01 |
2. Construction of Isatis tinctoria leaf cDNA library
Reverse transcription of Isatis tinctoria leaf Total RNAcDNA: total RNA was placed on ice, and the reagent and consumable material of RNase-free were used, and the experimental procedure was carried out with reference to the kit (TaKaRa PrimeScript) TM 1st strand cDNA Synthesis Kit)。
3. Amplification primer design: primer sequences for gene amplification are shown in Table 2.
TABLE 2
Primer name | Sequence (5 '-3') |
IiCOMT1-F | ATGGGATCAACGGCGGAGA |
IiCOMT1-R | TCAGATCTTCTTGAGCAACTCAA |
IiCOMT2-F | ATGGACTCAACGGCGGAGA |
IiCOMT2-R | TTAGATCTTCTTGTGCAGCTCAAT |
IiCOMT3-F | ATGGGCTCAGCGGCGGAGA |
IiCOMT3-R | TTAGATCTTCTTGTGCAGCTCAAT |
IiCOMT4-F | ATGGGCTCAACGGTGGACC |
IiCOMT4-R | TCAGAACTTCTTGAGCATCTCAATG |
4. Gene amplification
The experimental procedure is carried out with reference to the instructions of the kit (TOYOBO KOD FX cat# 9503002); the preparation of the reaction solution is shown in Table 3, and the PCR procedure is shown in Table 4. The resulting PCR product was electrophoresed on a 0.8% agarose gel (150V, 15 min) and the result was shown in FIG. 1.
TABLE 3 formulation of PCR reaction solution
Component (A) | Sample addition amount |
Stencil (cDNA) | 1μL |
F(10μM) | 1.5μL |
R(10μM) | 1.5μL |
2×KOD FX buffer | 25μL |
2mM dNTPs | 10μL |
KOD FX | 1μL |
Nuclase-free Water | Supplement to 50 mu L |
TABLE 4PCR reaction procedure
5. Ligation of amplification products to PMD19-T vectors
The amplified product was amplified using a Premix Taq enzyme (TaKaRa Premix LA) Continuing the amplification, a T was added to the end of the KOD FX enzyme-amplified product sequence, and the sample was added as shown in Table 5.
TABLE 5
Component (A) | Sample addition amount |
IiCOMT1/2/3/4 amplification products | 40μL |
Premix Taq | 1μL |
Reacting the mixed system at 72 ℃ for 20min;
amplification product-ligation PMD19-T vector was loaded as in Table 6, gently mixed, reacted at room temperature for 1h, and placed on ice after the reaction (experimental procedure reference kit TaKaRa PMD TM 19-T Vector Cloning Kit)。
TABLE 6
Component (A) | Sample application volume |
PCR products | 2.5μL |
PMD19-T | 0.5μL |
SolutionⅠ | 2μL |
6. Transformation of E.coli with vector
Experimental procedure reference kit (Weidi biological TOP10 Chemically Competent Cell)
(1) Taking out competent cells from a refrigerator at-80 ℃, thawing at room temperature, and rapidly placing on ice;
(2) 5. Mu.L of ligation product was added to 50. Mu.L of competent cells (performed in a super clean bench);
(3) Placing on ice for 30min, heat-shocking at 42 deg.C for 90s, and immediately placing on ice for 5min;
(4) Adding 500. Mu.L of LB culture solution without antibiotics, shaking at 37 ℃ and 200rpm for about 1 hour;
(5) Centrifuging at 5000rpm for 1min at room temperature, leaving 100 μl supernatant, and blowing for resuspension;
(6) Coating the suspension on LB solid medium containing 100mg/L Amp+, and placing the suspension in a constant temperature incubator at 37 ℃ for culturing for 12-16h;
(7) 8 monoclonal colonies were inoculated into 300. Mu.L of LB liquid medium containing 100mg/L of Amp+ and shake-cultured at 37℃for 3 hours or more at 200 rpm.
7. Monoclonal positive bacteria detection
a. The preparation of the reaction solution is shown in Table 7, and the PCR procedure is shown in Table 8. The result of 0.8% agarose gel electrophoresis (150V, 15 min) of the PCR product is shown in FIG. 2.
TABLE 7PCR reaction liquid formulation
Component (A) | Sample addition amount |
Stencil (fungus liquid) | 1μL |
M13-F(10μM) | 1μL |
M13-R(10μM) | 1μL |
2×Flash PCR MasterMix(Dye) | 10μL |
ddH2O | To 20. Mu.L |
TABLE 8PCR reaction program Table
8. Sequencing
Positive bacteria with matched bands were selected, 100. Mu.L was taken and tested (manufactured), and sequence alignment was performed using SnapGene software. Nucleotide sequences of IiCOMT1, iiCOMT2, iiCOMT3 and IiCOMT4 are shown in SEQ ID No.5-8 respectively. The coded protein sequences are shown in SEQ ID No.1-4 respectively.
EXAMPLE 2 construction of prokaryotic expression vectors
1. Extraction of plasmids
mu.L of the bacterial liquid COMT1/2/3/4-PMD19 with correct sequencing is taken and added into 20mL of LB (amp+100 mg/L) culture medium, and the bacterial liquid is cultured overnight in a constant temperature shaking table at 37 ℃ and 200 rpm. Meanwhile, 20. Mu.L of bacterial liquid pET28a+ -T1 was added to 20mL of LB (Ka+100 mg/L) medium, and cultured overnight in a constant temperature shaker at 37℃and 200 rpm. The cells were lysed, the supernatant was collected by centrifugation, the supernatant was collected by column chromatography, washed and centrifuged, and the plasmid solution was eluted (plasmid extraction step was performed with reference to kit EasyPure Plasmid MiniPrep Kit whole gold EM 101).
pET28a+ plasmid double cleavage
The HindIII-HF (NEB) and SacI-HF (NEB) double digested pET28a+ vectors were used for COMT1/2/3/4 seamless cloning, and the reaction system is shown in the Table.
TABLE 9
System composition | Volume of |
Plasmid(s) | 30μL |
Hind III-HF | 1μL |
SacI-HF | 1μL |
Cutsmart Buffer | 5μL |
ddH2O | 13μL |
And (3) uniformly mixing the reaction solution, placing the reaction solution at 37 ℃ for digestion for 40min, detecting an enzyme digestion result by agarose gel electrophoresis, cutting off corresponding fragments, recovering gel to obtain a linear plasmid solution, and detecting the concentration and purity of the linear plasmid solution by using a micro ultraviolet spectrophotometer for further calculation. The linear plasmid solution can be stored at-20℃for one week.
3. Seamless cloning primer design
Primers used for seamless cloning (restriction endonuclease sites underlined) are shown in Table 10.
Table 10
Primer name | Sequence (5 '-3') |
PET28a-IiCOMT1-F | GGATCCGAATTCGAGCTCATGGGATCAACG |
PET28a-IiCOMT1-R | GAGTGCGGCCGCAAGCTTGATCTTCTTGAG |
PET28a-IiCOMT2-F | GGATCCGAATTCGAGCTCATGGACTCAACGGC |
PET28a-IiCOMT2-R | GAGTGCGGCCGCAAGCTTGATCTTCTTGT |
PET28a-IiCOMT3-F | GGATCCGAATTCGAGCTCATGGGCTCAGCG |
PET28a-IiCOMT3-R | GAGTGCGGCCGCAAGCTTGATCTTCTTGT |
PET28a-IiCOMT4-F | GGATCCGAATTCGAGCTCATGGGCTCAACGG |
PET28a-IiCOMT4-R | GAGTGCGGCCGCAAGCTTGAACTTCTTGAG |
4. Amplification of Gene fragments
Experimental procedure reference kit (TOYOBO KOD FX cat# 9503002), PCR reaction solution formulation and PCR procedure are shown in tables 11 and 12. The result of the PCR product was shown in FIG. 3 by electrophoresis on a 0.8% agarose gel (150V, 15 min).
TABLE 11 formulation of PCR reaction solution
TABLE 12PCR reaction procedure
5. Seamless cloning
a. Preparing reaction solution according to Table 13, gently mixing, metal bath at 50deg.C for 30min, and immediately placing on ice or cooling to 4deg.C (step reference test)Agent boxplus One step PCR Cloning Kit offshore).
TABLE 13
b. Coli competent Trans1-T1 (Experimental procedures refer to kit Trans1-T1 Phage Resistant Chemically Competent Cell full gold CD 501).
c. Plating, picking spots, adding 500 mu L LB (Ka+100 mg/L), 37 ℃, shaking at 200rpm, overnight, checking, and carrying out sequence alignment.
6. Extracting plasmid and transforming expression strain BL21
Sequencing the correct COMT1/2/3/4-pET28a-Trans1-T1 and pET28a+ -T1 bacterial liquid, taking 20 mu L of the bacterial liquid in 20mL of LB (Ka+100 mg/L) liquid culture medium, shaking overnight at 37 ℃ at 200rpm, extracting the plasmid the next day, and re-transforming BL21 (the method is competent with Trans 1-T1). Plating and culturing overnight in a constant temperature incubator at 37 ℃. Spot picking, bacterial inspection and positive clone strain remaining.
EXAMPLE 3 protein Induction and purification
1. Protein-induced expression
a. mu.L of each of the bacterial solutions COMT1/2/3/4-pET28a-BL21 and pET28a+ -BL21 (as a negative control) was added to 0.5mL of LB (containing kanamycin Ka+100 mg/L) medium, cultured overnight, and activated twice.
b. mu.L of the bacterial liquid was added to 5mL of LB medium (containing kanamycin Ka+100 mg/L) and incubated at 200rpm at 37℃for about 6 hours. Then 1mL of bacterial liquid is added into 200mL of LB (containing Ka+100 mg/L) culture medium and cultured at 200rpm and 37 ℃ until the OD600 value reaches 0.5-0.6;
c. isopropyl- β -D-thiogalactoside (IPTG) was added to give a final concentration of 1mmol/L and incubated overnight (48 h) at 80rpm at 18 ℃;
centrifugation at 45,000rpm for 15min to enrich the cells, separate collection into 50mL centrifuge tubes, re-suspension with 20mL PBS buffer (ph=7.4), re-centrifugation to remove supernatant; the cells were resuspended in 20mL of PBS buffer (ph=7.4).
e.200w (variable level rod 3, power 35%), 2s ultrasonic, 4s interval ultrasonic crushing on ice for 15min, bacterial liquid temperature must not exceed 4 ℃;
f. the sonicated solution was centrifuged at 12,000rpm at 4℃for 15min, and the supernatant was collected as a crude protein solution. (in the preliminary experiment, 1mL of the sonicated solution was centrifuged at 12,000rpm at 4℃for 15min, and the supernatant, i.e., the crude protein solution, was collected and the pellet was resuspended in an equal volume of 1 XPBS buffer.)
SDS-PAGE electrophoretic analysis
20. Mu.L of each of the supernatant and the precipitate obtained in the above experiment was added to 4. Mu.L of a protein loading buffer (6X protein loading buffer), and the mixture was boiled in water for 8 minutes (heat denaturation was carried out for 2 minutes at 12,000 rpm), and SDS-PAGE analysis was carried out on the supernatant.
a. 10% SDS-PAGE gels were prepared and the separate and concentrated gel formulations are shown in Table, which shows the amounts of the two gels. Firstly, adding the separating gel into a gel preparation tank, adding the concentrated gel after solidifying for about 30min, and rapidly inserting a tooth comb. Immediately after solidification or after wrapping with soaked absorbent paper, the mixture is stored at 4 ℃.
Table 14 formulations of separator gel and concentrate gel
b. Taking 8 mu L of denatured sample supernatant, uniformly adding the sample supernatant into a lane of a concentrated gel, and using a Bio-Rad electrophoresis device, wherein the electrophoresis program is as follows: 80V 20min,120V 60min.
c. After the reaction is finished, taking out the gel, carefully cutting the gel, concentrating the gel, placing the gel in a glass plate with coomassie brilliant blue fast dye liquor, oscillating for about 10-30min by a side oscillating table, taking out the gel, placing the gel in clear water, heating for 30s by using a microwave oven with medium fire, decoloring, and repeating for a plurality of times until protein strips are obviously visible.
d. Analysis of results: the molecular weight of the IiCOMT1 protein was predicted to be 39.75kDa, the molecular weight of the IiCOMT2 protein was predicted to be 39.76kDa, the molecular weight of the IiCOMT3 protein was predicted to be 39.89kDa, and the molecular weight of the IiCOMT4 protein was predicted to be 39.83kDa. The results are shown in the figure, in which both the supernatant and the pellet are present for the proteins of interest IiCOMT1, 2, 3, 4, and in which the supernatant and pellet of empty pet28+ are free of bands at the corresponding positions.
3. Protein purification
The solutions required for purification were prepared according to Table 15 using a Bio-ScaleTM Mini ProfinityTM IMAC Cartridges purification column, and ultrapure water was added to 1000mL, KOH or H 3 PO 4 The pH is regulated to 7.4,0.22 mu m microporous filter membrane for filtration, and the mixture is placed at 4 ℃ for standby.
TABLE 15 buffer formulation table
a. Passing the obtained crude protein supernatant and each buffer solution through a 0.22 μm microporous filter membrane;
b. the column was equilibrated with 5 column volumes (5 mL) of wash buffer 1 and slowly rinsed at 2mL/min;
c. feeding the crude protein liquid at a concentration of 2mL/min;
d. sequentially using a wash buffer 1 and a wash buffer 2 with the volume of 6 times of the column, wherein the flow rate is 2mL/min;
e. eluting the sample by using a column volume of 10 times, collecting fractions purified by target proteins (pre-experiment: 1.5mL of eluent is respectively collected by a centrifuge tube and sequentially numbered each 1mL of eluent), and slowly eluting at 2mL/min;
f. after elution, the column was slowly rinsed with 5 column volumes of wash buffer 1 at 2 mL/min.
Note that: to avoid protein degradation, each of the above steps was performed on ice.
4. Protein concentration
In the preliminary experiment, the protein eluents collected respectively are subjected to SDS-PAGE gel electrophoresis detection, and according to the electrophoresis result, samples with larger protein concentration are combined (as shown in the figure, 4-12mL of components are collected, the pure protein collection components are not changed along with the loading amount of crude protein generally), and a millipore molecular sieve concentration column (50 kDa) is used for concentrating the protein samples, so that the purpose of desalting is achieved.
Centrifuging at a temperature of 4 ℃ to be less than 5000 Xg, and concentrating to a volume of 0.5-1mL.
b. Then, 3mL of PBS buffer was added, and the mixture was concentrated by centrifugation to a volume of less than 500. Mu.L.
c. The concentrated protease was placed on ice for subsequent experiments.
Sequencing shows that the amino acid sequence of the obtained Isatis tinctoria caffeic acid-O-methyltransferase protein IiCOMT1-4 is shown as SEQ ID No. 1-4.
5. Protein concentration detection
Purified protein concentration was measured using the bi-yun-Tian BCA protein concentration assay kit (enhanced) product number P0010 BCA.
0.4mg/mL protein Standard solution (BCA) was added to 96-well plates at 0, 1.25, 2.5, 5, 10, 15, 20. Mu.L, respectively, and PBS buffer was added to 20. Mu.L, and repeated twice. Diluting the purified protein solution for 50 times, 100 times, 200 times and 400 times, and repeating twice;
b. 200 mu L of freshly prepared BCA working solution is added into each hole, and the mixture is kept stand for 30min at 37 ℃;
detecting the absorbance of each hole at the wavelength of 630 nm;
d. the protein concentration was calculated by plotting a standard curve according to the absorbance of the protein standard solution as shown in table 16 below:
table 16
Example 4 in vitro enzyme function validation
Control group: inducible expression of pET28a+ -BL21 protein
Experimental group: the IiCMOT1/2/3/4-pET28a+ -BL21 protein induces expression. ( And (3) injection: in the preliminary experiment, crude protein liquid in the "protein induced expression" of the example 3 is used for enzyme activity verification, and purification is not needed; in the formal experiments, the enzymatic reaction used a purified enzyme in PBS and the control group was replaced with PBS buffer at the same pH. )
A substrate: caffeol, caffeic acid, 5-hydroxyferulic acid (5-hydroxyferulic acid), quercetin, luteolin.
The reaction system is shown in Table 17, and the reaction conditions are as follows: in a constant temperature mixer, 37℃at 300rpm,30min.
TABLE 17 in vitro recombinant enzyme activity reaction system
Component (A) | Sample addition amount |
1M Tris-Hcl(pH=7.5) | 20μL |
20mM MgCl 2 | 10μL |
5mM SAM | 10μL |
40mM DTT | 10μL |
IiCMOT1/2/3/4 purified enzyme | 4μg |
Substrate(s) | 1μL |
ddH 2 O | Add to 100μL |
After the completion of the reaction, the reaction was quenched with 100. Mu.L of absolute ethanol. Centrifuging at 12000 Xg and 4deg.C for 30min. 100 mu L of the supernatant was taken in a sample injection vial, and the sample was measured.
A qualitative determination of a sample of the reaction product was performed using Agilent Technologies 1260 affinity II LC.
Chromatographic conditions: the chromatographic column is Agilent ZORBAX Eclipse XDB-C18,5 μm,4.6x150mm, the flow rate is 1.0mL/min, the sample injection is 10. Mu.L, the detection wavelength is 260nm, 280nm, 320nm and 350nm, and the analysis conditions are as follows:
TABLE 18 analysis conditions for phenylpropanoid Compounds as substrates
Table 19 analysis conditions for flavonoids as substrates
Time/min | Mobile phase B (CH 3 OH) | Mobile phase D (0.1% acetic acid water) |
0 | 35% | 65% |
20 | 65% | 35% |
25 | 100% | - |
30 | 35% | 65% |
Analysis of results: as shown in FIG. 7, the ferulic acid standard showed a peak at 13.5min, and the caffeic acid was used as a substrate, and the same peak as the ferulic acid standard was found at 13.5min in the enzyme activity reaction system to which the IiCOMT1, 2, 3, and 4 enzymes were added, whereas the same peak as the ferulic acid standard was not found in the control enzyme activity reaction system of pET28a+ blank carrier, so IiCOMT1, 2, 3, and 4 could catalyze the methylation of caffeic acid to ferulic acid.
As shown in FIG. 2, coniferyl alcohol standard shows a peak at 11.25min, caffeol is used as a substrate, the same peak as the coniferyl alcohol standard exists at 11.25min in an enzyme activity reaction system added with IiCOMT1, 2, 3 and 4 enzymes, and the same peak as the coniferyl alcohol standard does not exist in a control enzyme activity reaction system of pET28 a+blank carrier, so that IiCOMT1, 2, 3 and 4 can catalyze caffeol methylation to generate coniferyl alcohol.
As shown in FIG. 3, the sinapic acid standard showed a peak at 13.58min, and 5-hydroxyferulic acid was used as a substrate, and the same peak as the sinapic acid standard was found at 13.58min in the enzyme activity reaction system to which IiCOMT1, 2, 3, 4 was added, whereas the same peak as the sinapic acid standard was not found in the control enzyme activity reaction system of pET28a+ blank carrier, so that IiCOMT1, 2, 3, 4 could catalyze 5-hydroxyferulic acid to produce sinapic acid.
As shown in FIG. 4, the isorhamnetin standard showed peaks at 23.48min, quercetin was used as a substrate, and the isorhamnetin standard showed peaks at 23.48min in the enzyme activity reaction system to which IiCOMT1, 2, 3, 4 was added, whereas the isorhamnetin standard showed no peaks in the control enzyme activity reaction system of pET28a+ blank vector, so IiCOMT1, 2, 3, 4 could catalyze the methylation of quercetin to isorhamnetin.
As shown in FIG. 5, the chrysoeriol standard substance shows a peak at 24.56min, luteolin is used as a substrate, the same peak as the chrysoeriol standard substance exists at 24.56min in an enzyme activity reaction system added with the enzymes IiCOMT1, 2, 3 and 4, and the same peak as the chrysoeriol standard substance does not exist in a control enzyme activity reaction system of the pET28a+ blank carrier, so that the luteolin can be catalyzed by the enzyme IiCOMT1, 2, 3 and 4 to generate the chrysoeriol through methylation.
The foregoing is a further detailed description of the invention in connection with specific embodiments, and it is not intended that the invention be limited to such description. Several equivalent substitutions or obvious modifications are made to the technical field of the present invention without departing from the concept of the present invention, and the performances or the uses are the same or similar, and all the equivalent modifications and obvious modifications are intended to fall within the protection scope of the present invention.
Sequence listing
<120> Isatis tinctoria caffeic acid-O-methyltransferase COMT protein, and encoding gene and application thereof
<130> W-21-1-02416
<160> 8
<170> SIPOSequenceListing 1.0
<210> 1
<211> 364
<212> PRT
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 1
Met Gly Ser Thr Ala Glu Thr Gln Ile Thr Pro Val Gln Val Thr Asp
1 5 10 15
Asp Glu Ala Ala Leu Phe Ala Met Gln Leu Ala Ser Ala Ser Val Leu
20 25 30
Pro Met Val Leu Lys Ser Ala Leu Asp Leu Asp Leu Leu Glu Ile Met
35 40 45
Ala Lys Asn Ser Ser Pro Met Ser Pro Ser Glu Ile Ala Ser Lys Leu
50 55 60
Gln Thr Lys Asn Pro Glu Ala Pro Val Met Leu Asp Arg Ile Leu Arg
65 70 75 80
Leu Leu Thr Ser Tyr Ser Ile Leu Thr Cys Ser Asn Arg Thr Ile Pro
85 90 95
Gly Gly Asp Gly Val Glu Arg Ile Tyr Gly Leu Gly Pro Val Cys Lys
100 105 110
Tyr Leu Thr Lys Asn Glu Asp Gly Val Ser Ile Ala Ala Leu Cys Leu
115 120 125
Met Asn Gln Asp Lys Val Leu Met Glu Ser Trp Tyr His Leu Lys Asp
130 135 140
Ala Ile Leu Asp Gly Gly Ile Pro Phe Asn Lys Ala Tyr Gly Met Ser
145 150 155 160
Ala Phe Glu Tyr His Gly Lys Asp Leu Arg Phe Asn Thr Val Phe Asn
165 170 175
Asn Gly Met Ser Asn His Ser Thr Ile Thr Met Lys Lys Ile Leu Glu
180 185 190
Thr Tyr Lys Gly Phe Glu Gly Leu Thr Ser Leu Val Asp Val Gly Gly
195 200 205
Gly Ile Gly Ala Thr Leu Lys Met Ile Val Ser Lys Tyr Pro Asn Leu
210 215 220
Lys Gly Ile Asn Phe Asp Leu Pro His Val Ile Glu Glu Ala Thr Ser
225 230 235 240
His Pro Gly Ile Glu His Val Gly Gly Asp Met Phe Val Ser Val Pro
245 250 255
Lys Gly Asp Ala Ile Phe Met Lys Trp Ile Cys His Asp Trp Ser Asp
260 265 270
Glu His Cys Val Lys Phe Leu Lys Asn Cys Tyr Glu Ser Leu Pro Glu
275 280 285
Asp Gly Lys Val Ile Leu Ala Glu Cys Ile Leu Pro Glu Thr Pro Asp
290 295 300
Ser Ser Leu Ser Thr Lys Gln Val Val His Val Asp Cys Ile Met Leu
305 310 315 320
Ala His Asn Pro Gly Gly Lys Glu Arg Thr Glu Lys Glu Phe Glu Ala
325 330 335
Leu Ala Lys Gly Ser Gly Phe Lys Gly Ile Asn Val Ala Cys Asn Ala
340 345 350
Phe Gly Val Tyr Val Ile Glu Leu Leu Lys Lys Ile
355 360
<210> 2
<211> 362
<212> PRT
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 2
Met Asp Ser Thr Ala Glu Thr Gln Leu Thr Pro Val Gln Val Thr Glu
1 5 10 15
Asp Glu Thr Ile Leu Phe Ala Thr Gln Leu Ala Ser Ala Ser Val Leu
20 25 30
Pro Met Ala Leu Lys Thr Thr Ile Glu Leu Asp Val Leu Glu Ile Met
35 40 45
Ala Lys Asn Ser Ser Pro Met Ser Ala Ser Glu Ile Val Ser His Leu
50 55 60
Pro Thr Lys Asn Pro Glu Ala Thr Val Met Leu Asp Arg Ile Leu Arg
65 70 75 80
Leu Leu Ala Ala Tyr Ser Ile Leu Thr Cys Ser Val Arg Thr Leu Pro
85 90 95
Asp Gly Val Asp Arg Leu Tyr Gly Leu Gly Pro Val Cys Lys Tyr Leu
100 105 110
Thr Lys Asn Glu Asp Gly Val Ser Ile Ala Ala Leu Cys Leu Met Asn
115 120 125
His Asp Lys Val Leu Met Glu Ser Trp Tyr His Leu Lys Asp Ala Ile
130 135 140
Leu Asp Gly Gly Ile Pro Phe Asn Lys Ala Tyr Gly Met Ser Ala Phe
145 150 155 160
Glu Tyr His Gly Thr Asp Leu Arg Phe Asn Lys Val Phe Asn Asn Gly
165 170 175
Met Ser Asn His Thr Thr Ile Ser Met Lys Lys Ile Leu Glu Thr Tyr
180 185 190
Lys Gly Phe Glu Gly Leu Thr Ser Leu Val Asp Val Gly Gly Gly Ile
195 200 205
Gly Ala Thr Leu Lys Met Ile Val Ser Lys Tyr Pro Asn Leu Lys Gly
210 215 220
Ile Asn Phe Asp Leu Pro Tyr Val Ile Ala Asp Ala Pro Pro Tyr Pro
225 230 235 240
Gly Val Glu Tyr Val Gly Gly Asp Met Phe Val Ser Val Pro Lys Gly
245 250 255
Asp Ala Ile Phe Met Lys Trp Ile Cys His Asp Trp Ser Asp Glu His
260 265 270
Cys Val Lys Ile Leu Lys Asn Cys Tyr Glu Ala Leu Pro Glu Asn Gly
275 280 285
Lys Val Ile Ile Ala Glu Ser Ile Leu Pro Glu Thr Leu Asp Ser Ser
290 295 300
Leu Leu Thr Lys Gln Val Val His Val Asp Cys Ile Met Leu Ala His
305 310 315 320
Asn Pro Gly Gly Lys Glu Arg Thr Ala Lys Glu Phe Glu Ala Leu Ala
325 330 335
Lys Gly Ser Gly Phe Lys Gly Phe Lys Val Val Cys Asn Thr Phe Gly
340 345 350
Ile Tyr Leu Ile Glu Leu His Lys Lys Ile
355 360
<210> 3
<211> 364
<212> PRT
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 3
Met Gly Ser Ala Ala Glu Thr Gln Ile Thr Pro Val Gln Val Thr Asp
1 5 10 15
Asp Glu Thr Arg Leu Phe Ala Met Gln Leu Ala Ser Ala Ser Val Leu
20 25 30
Pro Met Val Leu Lys Ser Ala Leu Asp Leu Asp Leu Leu Glu Ile Met
35 40 45
Ala Lys Asn Ser Ser Pro Met Ser Pro Ser Glu Ile Ala Ser Lys Leu
50 55 60
Gln Thr Lys Asn Pro Glu Ala Pro Val Met Leu Asp Arg Ile Leu Arg
65 70 75 80
Leu Leu Thr Ser Tyr Ser Ile Leu Thr Cys Ser Asn Arg Thr Ile Pro
85 90 95
Gly Gly Asp Gly Val Glu Arg Ile Tyr Gly Leu Gly Pro Val Cys Lys
100 105 110
Tyr Leu Thr Lys Asn Glu Asp Gly Val Ser Ile Ala Ala Leu Cys Leu
115 120 125
Met Asn Gln Asp Lys Val Leu Met Glu Ser Trp Tyr His Leu Lys Asp
130 135 140
Ala Ile Leu Asp Gly Gly Ile Pro Phe Asn Lys Ala Tyr Gly Met Ser
145 150 155 160
Ala Phe Glu Tyr His Gly Lys Asp Leu Arg Phe Asn Thr Val Phe Asn
165 170 175
Asn Gly Met Ser Asn His Ser Thr Ile Thr Met Lys Lys Ile Leu Glu
180 185 190
Thr Tyr Lys Gly Phe Glu Gly Leu Thr Ser Leu Val Asp Val Gly Gly
195 200 205
Gly Ile Gly Ala Thr Leu Lys Met Ile Val Ser Lys Tyr Pro Asn Leu
210 215 220
Lys Gly Ile Asn Phe Asp Leu Pro His Val Ile Glu Glu Ala Thr Ser
225 230 235 240
His Pro Gly Ile Glu His Val Gly Gly Asp Met Phe Val Ser Val Pro
245 250 255
Lys Gly Asp Ala Ile Phe Met Lys Trp Ile Cys His Asp Trp Ser Asp
260 265 270
Glu His Cys Val Lys Phe Leu Lys Asn Cys Tyr Glu Ser Leu Pro Glu
275 280 285
Asp Gly Lys Val Ile Leu Ala Glu Cys Ile Leu Pro Glu Thr Pro Asp
290 295 300
Ser Ser Leu Ser Thr Lys Gln Val Val His Val Asp Cys Ile Met Leu
305 310 315 320
Ala His Asn Pro Gly Gly Lys Glu Arg Thr Glu Lys Glu Phe Glu Ala
325 330 335
Leu Ala Lys Gly Ser Gly Phe Lys Gly Ile Asn Val Asp Cys Asn Ala
340 345 350
Phe Gly Val Tyr Val Ile Glu Leu His Lys Lys Ile
355 360
<210> 4
<211> 364
<212> PRT
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 4
Met Gly Ser Thr Val Glu Thr Gln Ile Thr Pro Val Gln Val Thr Asp
1 5 10 15
Asp Glu Ala Ala Leu Phe Ala Met Gln Leu Ala Ser Ala Ser Val Leu
20 25 30
Pro Met Val Leu Lys Ser Ala Leu Asp Leu Asp Leu Leu Glu Ile Met
35 40 45
Ala Lys Asn Ser Ser Pro Met Ser Pro Ser Glu Ile Ala Ser Lys Leu
50 55 60
Gln Thr Lys Asn Pro Glu Ala Pro Val Met Leu Asp Arg Ile Leu Arg
65 70 75 80
Leu Leu Thr Ser Tyr Ser Ile Leu Thr Cys Ser Asn Arg Thr Ile Pro
85 90 95
Gly Gly Asp Gly Val Glu Arg Ile Tyr Gly Leu Gly Pro Val Cys Lys
100 105 110
Tyr Leu Thr Lys Asn Glu Asp Gly Val Ser Ile Ala Ala Leu Cys Leu
115 120 125
Met Asn Gln Asp Lys Val Leu Met Glu Ser Trp Tyr His Leu Lys Asp
130 135 140
Ala Ile Leu Asp Gly Gly Ile Pro Phe Asn Lys Ala Tyr Gly Met Ser
145 150 155 160
Ala Phe Glu Tyr His Gly Lys Asp Leu Arg Phe Asn Thr Val Phe Asn
165 170 175
Asn Gly Met Ser Asn His Ser Thr Ile Thr Met Lys Lys Ile Leu Glu
180 185 190
Thr Tyr Lys Gly Phe Glu Gly Leu Thr Ser Leu Val Asp Val Gly Gly
195 200 205
Gly Ile Gly Ala Thr Leu Lys Met Ile Val Ser Lys Tyr Pro Asn Leu
210 215 220
Lys Gly Ile Asn Phe Asp Leu Pro His Val Ile Glu Glu Ala Thr Ser
225 230 235 240
His Pro Gly Ile Glu His Val Gly Gly Asp Met Phe Val Ser Val Pro
245 250 255
Lys Gly Asp Ala Ile Phe Met Lys Trp Ile Cys His Asp Trp Ser Asp
260 265 270
Glu His Cys Val Lys Phe Leu Lys Asn Cys Tyr Glu Ser Leu Pro Glu
275 280 285
Asp Gly Lys Val Ile Leu Ala Glu Cys Ile Leu Pro Glu Thr Pro Asp
290 295 300
Ser Ser Leu Ser Thr Lys Gln Val Val His Val Asp Cys Ile Met Leu
305 310 315 320
Ala His Asn Pro Gly Gly Lys Glu Arg Thr Glu Lys Glu Phe Glu Ala
325 330 335
Leu Ala Lys Gly Ser Gly Phe Lys Gly Ile Asn Val Ala Cys Asn Ala
340 345 350
Phe Gly Val Tyr Val Ile Glu Met Leu Lys Lys Phe
355 360
<210> 6
<211> 1095
<212> DNA
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 6
atgggatcaa cggcggagac acagataact ccggtacaag tcactgacga cgaagccgct 60
ctcttcgcca tgcagctagc gagtgcctcc gttcttccga tggttttaaa atcggcatta 120
gacctcgatc ttctcgagat catggccaag aactcttctc cgatgtctcc gtctgagatt 180
gcttctaaac ttcagaccaa aaaccccgaa gctccggtca tgctcgaccg tatcctccgt 240
cttcttacct cttactccat cctcacctgc tccaaccgta ctattcccgg cggcgacggc 300
gtcgagagga tttacgggct tggtccggtt tgcaagtatc tgaccaagaa cgaggatggt 360
gtctcgattg ctgctctttg tcttatgaac caagacaagg ttctcatgga aagctggtac 420
catttgaaag atgcaattct tgatggtggg atcccattca acaaggctta tggaatgagc 480
gcgttcgagt accatgggaa ggaccttagg ttcaacacgg tcttcaacaa tggaatgtct 540
aaccattcaa ccatcacaat gaagaagatt ctcgagacct ataagggttt cgagggtttg 600
acttctttgg ttgacgttgg tggtggcatt ggtgctactc tcaaaatgat tgtctccaag 660
taccctaacc tcaaaggcat caactttgat ctccctcatg tcatcgaaga agctacttct 720
caccctggta ttgaacatgt tggaggagat atgtttgtga gtgtccctaa aggtgatgcc 780
attttcatga agtggatatg ccacgattgg agcgacgaac actgcgtgaa attcttgaaa 840
aactgctacg agtcgcttcc agaggatgga aaagttatat tagcagagtg tatacttcca 900
gagacaccag actcaagcct ctcgaccaaa caagtagtcc atgtcgactg cattatgttg 960
gcccacaatc ctggaggcaa agaacggacc gagaaagagt tcgaggcatt agctaaagga 1020
tcaggcttca aaggcatcaa cgttgcctgc aacgcttttg gtgtttacgt tattgagttg 1080
ctcaagaaga tctga 1095
<210> 6
<211> 1089
<212> DNA
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 6
atggactcaa cggcggagac acagttaact ccagtgcaag tcaccgaaga cgaaactatc 60
ctcttcgcca cacagttagc cagtgcctcc gttcttccta tggctttaaa aacgactata 120
gagctcgatg ttctcgagat catggccaag aactcttcac ctatgtctgc gtctgagatc 180
gtttctcatc ttccgaccaa aaaccccgaa gcgacggtca tgctcgaccg tatcctccgt 240
cttcttgcgg cttactccat cctcacctgc tccgtccgta cacttcccga cggcgtcgac 300
cgactttacg ggcttggtcc ggtttgcaag tatttgacca agaacgaaga tggtgtctcg 360
attgctgctc tctgtctcat gaaccatgac aaggtcttaa tggaaagctg gtaccatctg 420
aaagatgcaa ttcttgatgg tgggattcca ttcaacaaag cttatggcat gagcgcgttc 480
gagtaccatg ggactgacct tagattcaac aaggtgttca ataatggaat gtctaaccat 540
accaccatct caatgaagaa gattctcgag acctataagg gtttcgaggg attgacttct 600
ttggttgatg ttggtggtgg cattggagct acactcaaaa tgatagtctc taagtaccct 660
aaccttaaag ggatcaactt tgatctccct tatgtcattg cagatgctcc tccttatccc 720
ggtgttgagt atgttggagg agatatgttt gtaagtgtcc ccaaaggtga tgccattttc 780
atgaagtgga tatgccatga ttggagtgac gaacactgtg tgaaaatctt gaagaattgc 840
tacgaggcgc ttccggagaa tggaaaagtg ataatagcag agagcatact tccagaaaca 900
ctagattcaa gcctcttgac caaacaagtt gtccacgttg attgcattat gttggctcac 960
aatcctggag gcaaagaacg gaccgcgaaa gagtttgagg cattagccaa aggatcaggc 1020
ttcaaaggct tcaaagttgt ttgcaacacc tttggtattt accttattga gctgcacaag 1080
aagatctaa 1089
<210> 7
<211> 1095
<212> DNA
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 7
atgggctcag cggcggagac acagataact ccggtacaag tcactgacga cgaaacccgc 60
ctcttcgcca tgcagctagc gagtgcctcc gttcttccga tggttttaaa atcggcatta 120
gacctcgatc ttctcgagat catggccaag aactcttctc cgatgtctcc gtctgagatt 180
gcttctaaac ttcagaccaa aaaccccgaa gctccggtca tgctcgaccg tatcctccgt 240
cttcttacgt cttactccat cctcacctgc tccaaccgta ctattcccgg cggcgacggc 300
gtcgagagga tttacgggct tggtccggtt tgcaagtatc tgaccaagaa cgaggatggt 360
gtctcgattg ctgctctttg tcttatgaac caagacaagg ttctcatgga aagctggtac 420
catttgaaag atgcaattct tgatggtggg atcccattca acaaggctta tggaatgagc 480
gcgttcgagt accacgggaa ggaccttagg ttcaacacgg tcttcaacaa tggaatgtct 540
aaccattcaa ccatcacaat gaagaagatt ctcgagacct ataagggttt cgagggtttg 600
acttctttgg ttgacgttgg tggtggcatt ggtgctactc tcaaaatgat tgtctccaag 660
taccctaacc tcaaaggcat caactttgat ctccctcatg tcatcgaaga agctacttct 720
caccctggta ttgaacatgt tggaggagat atgtttgtga gtgtccctaa aggtgatgcc 780
attttcatga agtggatatg ccacgattgg agcgacgaac actgcgtgaa attcttgaaa 840
aactgctacg agtcgcttcc agaggatgga aaagttatat tagcagagtg tatacttcca 900
gagacaccag actcaagcct ctcgaccaaa caagtagtcc atgtcgactg cattatgttg 960
gcccacaatc ctggaggcaa agaacggacc gagaaagagt ttgaggcatt agctaaagga 1020
tcaggcttca aaggcatcaa cgttgactgc aacgcttttg gtgtttacgt tattgagctg 1080
cacaagaaga tctaa 1095
<210> 8
<211> 1095
<212> DNA
<213> Isatis tinctoria (Isatis indigotica fort.)
<400> 8
atgggctcaa cggtggagac acagataact ccggtacaag tcactgacga cgaagccgct 60
ctcttcgcca tgcagctagc gagtgcctcc gttcttccga tggttttaaa atcggcatta 120
gacctcgatc ttctcgagat catggccaag aactcttctc cgatgtctcc gtctgagatt 180
gcttctaaac ttcagaccaa aaaccccgaa gctccggtca tgctcgaccg tatcctccgt 240
cttcttacgt cttactccat cctcacctgc tccaaccgta ctattcccgg cggcgacggc 300
gtcgagagga tttacgggct tggtccggtt tgcaagtatc tgaccaagaa cgaggatggt 360
gtctcgattg ctgctctttg tcttatgaac caagacaagg ttctcatgga aagctggtac 420
catttgaaag atgcaattct tgatggtggg atcccattca acaaggctta tggaatgagc 480
gcgttcgagt accacgggaa ggaccttagg ttcaacacgg tcttcaacaa tggaatgtct 540
aaccattcaa ccatcacaat gaagaagatt ctcgagacct ataagggttt cgagggtttg 600
acttctttgg ttgacgttgg tggtggcatt ggtgctactc tcaaaatgat tgtctccaag 660
taccctaacc tcaaaggcat caactttgat ctccctcatg tcatcgaaga agctacttct 720
caccctggta ttgaacatgt tggaggagat atgtttgtga gtgtccctaa aggtgatgcc 780
attttcatga agtggatatg ccacgattgg agcgacgaac actgcgtgaa attcttgaaa 840
aactgctacg agtcgcttcc agaggatgga aaagttatat tagcagagtg tatacttcca 900
gagacaccag actcaagcct ctcgaccaaa caagtagtcc atgtcgactg cattatgttg 960
gcccacaatc ctggaggcaa agaacggacc gagaaagagt tcgaggcatt agctaaagga 1020
tcaggcttca aaggcatcaa cgttgcctgc aacgcttttg gtgtttacgt tattgagatg 1080
ctcaagaagt tctga 1095
Claims (8)
1. Isatis tinctoria caffeic acid-O-methyltransferase, characterized in that the amino acid sequence is any one of the sequences of SEQ ID No. 1-4.
2. Isatis tinctoria caffeic acid-O-methyltransferase gene encoding the same according to claim 1.
3. The woad caffeic acid-O-methyltransferase gene according to claim 2, having a nucleotide sequence of any one of SEQ ID nos. 5-8.
4. A recombinant vector comprising a nucleotide sequence encoding the woad caffeic acid-O-methyltransferase according to claim 1.
5. The recombinant vector according to claim 4, which comprises the woad caffeic acid-O-methyltransferase gene according to claim 2 or 3.
6. A host cell comprising the woad caffeic acid-O-methyltransferase gene of claim 2 or 3 or the recombinant vector of claim 4 or 5.
7. Use of the woad-O-methyltransferase of claim 1, the woad-O-methyltransferase gene of claim 2 or 3, the recombinant vector of claim 4 or 5, or the host cell of claim 6 for the preparation of isorhamnetin or chrysoeriol.
8. A process for producing isorhamnetin or chrysoeriol, characterized by using the woad caffeic acid-O-methyltransferase according to claim 1, a recombinant vector or host cell capable of expressing the woad caffeic acid-O-methyltransferase according to claim 1 as a catalyst.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111031460.7A CN113774038B (en) | 2021-09-03 | 2021-09-03 | Isatis tinctoria caffeic acid-O-methyltransferase protein, encoding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111031460.7A CN113774038B (en) | 2021-09-03 | 2021-09-03 | Isatis tinctoria caffeic acid-O-methyltransferase protein, encoding gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113774038A CN113774038A (en) | 2021-12-10 |
CN113774038B true CN113774038B (en) | 2023-10-20 |
Family
ID=78841024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111031460.7A Active CN113774038B (en) | 2021-09-03 | 2021-09-03 | Isatis tinctoria caffeic acid-O-methyltransferase protein, encoding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113774038B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114891840B (en) * | 2022-05-23 | 2024-04-30 | 中国中医科学院中药研究所 | Lotus leaf O-methyltransferase and application of encoding gene thereof in synthesis of benzyl isoquinoline alkaloid and phenylpropionic acid compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101280315B (en) * | 2008-05-20 | 2010-09-01 | 中国农业科学院油料作物研究所 | Gene 4-CL for Chinese white poplar lignose monomer synthesis and application thereof |
-
2021
- 2021-09-03 CN CN202111031460.7A patent/CN113774038B/en active Active
Non-Patent Citations (3)
Title |
---|
ACCESSION:APG39836.1;LI,W.等;《GENBANK》;20161207;序列 * |
四倍体菘蓝中优良品质相关基因的克隆及研究;陆倍倍;《中国优秀硕士学位论文全文库 农业科技专辑》;20060915(第09期);第1-142页 * |
菘蓝中咖啡酰辅酶A氧甲基转移酶基因克隆与表达特征;李元玉 等;《分子植物育种》;20210707;第20卷(第02期);第349-356页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113774038A (en) | 2021-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4095145A1 (en) | New carbon glycoside glycosyltransferase and use thereof | |
CN112961870B (en) | Carbon glycosyltransferase DhCGT2 gene in pseudo-ginseng plant and application thereof | |
WO2020048523A1 (en) | Baicalein- and wild baicalein-synthesizing microorganism, preparation method for same, and applications thereof | |
CN113774038B (en) | Isatis tinctoria caffeic acid-O-methyltransferase protein, encoding gene and application thereof | |
CN111088254B (en) | Endogenous carried exogenous gene efficient controllable expression system | |
CN113265433A (en) | Bifunctional carbon glycoside glycosyl transferase and application thereof | |
CN113088502B (en) | Glycosylated transferase gene of Panax ginseng and application thereof | |
CN104357419B (en) | A kind of fleabane flower glycosyl transferase, preparation method and applications | |
CN116042547B (en) | Flavone 3' -hydroxylase and application thereof | |
CN112813084B (en) | Carbon glycosyltransferase DhCGT1 gene in pseudo-anethod plants and application thereof | |
CN112941063B (en) | Alpha-santalene synthetase, gene and application | |
CN114277024B (en) | Novel triterpene synthase and application thereof | |
CN116790545A (en) | Glycosyltransferase PpUGT2 for biosynthesis of rhizoma paridis saponin | |
WO2021057913A1 (en) | Preparation of glycosyltransferase ugt76g1 mutant and use thereof | |
CN112961869A (en) | Jasmonic acid amino acid synthetase JAR1 gene from red sage root and its coded protein and application | |
CN112921024A (en) | Alpha-guaialene synthetase, gene and application | |
CN114480448B (en) | Gene GbF3' H for promoting synthesis of ginkgo flavonol glycosides, and vector, protein and application thereof | |
CN110218711B (en) | Enzyme protein and coding gene and application thereof | |
CN110791483A (en) | Short-chain reductase and preparation method and application thereof | |
CN111826357A (en) | Scopolia acutangula atypical III type polyketide synthase and application thereof | |
CN115197921B (en) | Schisandra chinensis pinoresinol-lariciresinol reductase and encoding gene and application thereof | |
CN111073868B (en) | Plant flavone methyltransferase protein and coding gene and application thereof | |
CN111718911A (en) | FAD-dependent oxidase Ma-2 in Diels-Alder adduct anabolic pathway and application | |
CN110343680B (en) | Honeysuckle chalcone synthase mutant and application thereof | |
CN116970585A (en) | Gnaphalium affine caffeoyl transferase and encoding gene and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |